The Clinical Research with
Reishield
The bioavailability of Reishield compared to uncoated ferrous sulphate was evaluated in a two-way, randomized, double-blind, cross-over postprandial intervention in healthy volunteers by measuring two iron blood parameters: transferrin saturation.
This is a title
42mg of iron in the form of Reishield or ferrous sulphate (control) in dairy products.
Volunteers received 500 mL of either the test or the control products, together with a standardized breakfast.
Blood samples were collected at one-hour intervals for 6 hours after the end of the meal.
Results
Reishield has a bioavailability equivalent to that of ferrous sulphate.
Effects of Gl-PS on
immunophenotypes of splenocytes in Cy-treated mice Immunophenotypes were evaluated by determining the absolute numbers of splenocytes in Cy-treated mice on day 9. Compared to normal mice, the numbers of both CD3+ T lymphocytes and CD3+ NK1.1+ (NKT) cells in Cy-treated mice were decreased to a similar extend in all experimental groups (Table 3). Treatment with low- and intermediate-dose of Gl-PS rescued NK1.1+ cell numbers to the normal levels, an effect that was not mimicked in other treatment groups. In addition, treatment with low-dose Gl-PS significantly increased the number of NKT cells as compared to the saline vehicle group
